Cboe Global Markets is considering converting its Bitcoin and Ether continuous futures contracts into true perpetual futures, which never expire and settle continuously. This move follows recent US regulatory approval of crypto-native perpetual futures, notably by the CFTC's approval of Kalshi's bitcoin perpetual futures. The change would allow institutional investors to trade these popular crypto derivatives onshore under a regulated framework, potentially increasing trading volume and challenging competitors like CME Group. This shift marks a significant step in integrating crypto derivatives into traditional US finance.
The European Commission has approved Cenrifki (tolebrutinib) by Sanofi for treating secondary progressive multiple sclerosis (SPMS) without relapses, based on positive phase 3 trial results showing it delays disability progression. This is the first ...
argenx, a global immunology company, is hosting a webinar on June 23, 2026, focused on advancing research and development of FcRn blockers for autoimmune myositis. The event features argenx's management and scientific leaders alongside key external e...
Signify announced a new strategy at its 2026 Capital Markets Day to become a more focused and better-performing company by 2029. The plan includes prioritizing growth in connected lighting and consumer segments while optimizing less profitable areas....
The European Commission has approved Sanofi's Cenrifki (tolebrutinib) as the first medicine targeting disability progression in secondary progressive multiple sclerosis (SPMS) without relapses. Approval is based on positive phase 3 clinical trial res...
Akkodis' 2026 study reveals CTO confidence in scaling AI has fallen from 82% in 2024 to 48% in 2026, despite rapid AI adoption and increased investments. The main challenge is not technology but integrating AI into company systems, processes, and dec...
